Imexpharm

Imexpharm announces third quarter results

October 19, 2024 | 10:53

On October 18, Imexpharm Corporation announced its third quarter results.

Imexpharm’s ambitions to enter global pharma supply chain

September 23, 2024 | 09:00

Imexpharm is driving significant growth by boosting research and development into high-tech pharmaceuticals.

Imexpharm part of emerging trend of innovation in pharmaceuticals

August 28, 2024 | 09:00

Imexpharm Pharmaceutical JSC (IMP) is investing heavily in high-quality pharmaceutical production technology to meet international standards.

Imexpharm recognised at Top 50 Corporate Sustainability Awards

August 02, 2024 | 20:00

Imexpharm Pharmaceutical JSC was honoured at the Top 50 Corporate Sustainability Awards (CSA 2023) organised by Nhip Cau Dau Tu magazine on August 2.

Imexpharm announces interim results for H1

July 22, 2024 | 10:30

Imexpharm Corporation has announced its interim results for the first six months of 2024.

Imexpharm honoured with Vietnam Pharmaceutical Star award

May 20, 2024 | 15:10

Imexpharm Pharmaceutical JSC proudly received the “Vietnam Pharmaceutical Star” award for the second time today.

Imexpharm welcomes shareholders, analysts and potential investors at AGM

April 26, 2024 | 16:37

Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.

Outlook for pharmaceutical stocks in 2024

April 22, 2024 | 08:00

At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.

Imexpharm set growth record in 2023

April 02, 2024 | 08:00

Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.

Imexpharm joins Vietnam's campaign to plant one billion trees

March 22, 2024 | 14:04

Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.

Imexpharm forges partnership with Genuone Sciences

February 27, 2024 | 11:16

IMP has signed a strategic cooperation agreement with Genuone Sciences Inc.

Domestic pharmaceutical products anticipate 2024 boost

January 23, 2024 | 10:15

Despite a challenging 2023, the pharmaceutical industry remains healthy thanks to the breakthroughs of leading pharmaceutical companies.

Imexpharm clinches top honours in corporate annual reporting

December 28, 2023 | 14:18

Imexpharm has scored top honours in corporate governance.

SK Investment Vina III to hold 65 per cent of Imexpharm

December 28, 2023 | 11:20

SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.